MPLT MapLight Therapeutics, Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1770069 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-145.1%
TTM EPS YoY162.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-293.7%
ROA-68.6%
ROIC (approx.)-812.4%
Asset turnover—
Leverage & solvency
Liabilities / assets6.6%
Debt / equity0.00x
Current ratio9.53x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio-20.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $138.35M | $68.52M |
| SG&A expense | $30.73M | $14.42M |
| Operating income | -$169.08M | -$82.95M |
| Net income | -$161.15M | -$77.58M |
| EBITDA | -$168.50M | -$82.25M |
| EPS (basic) | -18.56 | -105.38 |
| EPS (diluted) | -18.56 | -105.38 |
| Weighted avg. shares (diluted) | 8.68M | 736,178 |
| Balance sheet | ||
| Cash & equivalents | $46.73M | $38.25M |
| Short-term investments | $258.37M | $70.54M |
| Current assets | $324.67M | $114.60M |
| PP&E, net | $1.09M | $1.21M |
| Total assets | $479.51M | $136.92M |
| Current liabilities | $16.23M | $15.92M |
| Total liabilities | $21.14M | $21.72M |
| Shareholders' equity | $458.37M | -$193.63M |
| Shares outstanding | 44.02M | 761,276 |
| Cash flow statement | ||
| Operating cash flow | -$138.14M | -$78.81M |
| Capital expenditure | $473,000 | $770,000 |
| Free cash flow | -$138.61M | -$79.58M |
| Investing cash flow | -$323.21M | -$80.79M |
| Financing cash flow | $469.82M | $118.06M |
| Depreciation & amortization | $578,000 | $701,000 |
| Stock-based compensation | $36.01M | $1.08M |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.